AXSM - CIK 0001579428
Axsome Therapeutics, Inc. (AXSM) reported revenue of $638.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $638.50M | +65.5% |
| FY 2024 | $385.69M | +42.5% |
| FY 2023 | $270.60M | - |
| FY 2022 | $0.00 | - |
Axsome Therapeutics, Inc. (AXSM) reported revenue of $638.50M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.